Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview


« Back to Dashboard
Cabergoline is a drug marketed by Apotex Corp, Par Pharm, Actavis Labs Fl Inc, Impax Labs Inc, Mylan Pharms Inc, and Ivax Sub Teva Pharms. and is included in six NDAs. It is available from six suppliers.

The generic ingredient in CABERGOLINE is cabergoline. There are eleven drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the cabergoline profile page.

Summary for Tradename: CABERGOLINE

Suppliers / Packagers: see list6
Drug Prices: :see details

Pharmacology for Tradename: CABERGOLINE

Drug ClassErgot Derivative

Clinical Trials for: CABERGOLINE

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apotex Corp
TABLET;ORAL201503-001Mar 8, 2013RXNo
Impax Labs Inc
TABLET;ORAL077843-001Jul 3, 2007DISCNNo
Par Pharm
TABLET;ORAL076310-001Dec 29, 2005RXYes
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.